Friday, September 29, 2006

SUPPORT GROUP: NEW YORK CITY

As you (yeah, you) might recall, the Greater New York City Celiac Support Group (CSA/USA, Inc.) called out for new leadership earlier this year. Due to the lack of response, the group has suspended its formal meetings for the time being. But the group's dinner meetings (not to be confused with the Meetup.com dinner meetings) will continue at
Bistango Restaurant
415 Third Avenue (at E. 29 St.)
Thursday, October 12, 2006 at 6:30 pm
RSVP by October 10 to Merle (212-662-2464) or Mary (212-304-1026).

Friday, September 22, 2006

VOICE OF AMERICA COVERAGE

Melinda Smith's video coverage of celiac disease for Voice of America in "An Ancient Genetic Disorder Gets Modern Day Attention" (September 5, 2005) starts off typically, with a shopping scene. But in just over four minutes, her Voice of America report touches on some unusual angles, including the impact of slow diagnoses, the importance of interpersonal efforts in boosting awareness of celiac disease, and the potentially harmful use of wheat in relief efforts.

Friday, September 15, 2006

SPELT IS STILL WHEAT!

The folks at Food & Wine might have been going a little heavy on the wine when they published Erin McKenna's recipe for Raspberry Scones. "Spelt, which is loaded with manganese and riboflavin, gives these wheat-free scones a wheaty taste," gushes the gulled magazine in its September 2006 issue.

I guess nobody managed to inform Food & Wine that there's a simple reason why spelt gives scones a wheaty taste: Spelt is actually a form of wheat.

In the same issue, Food & Wine also defines spelt flour as "A flour alternative for people with wheat allergies," parroting reckless marketing-speak while ignoring organizations such as the FDA and the Food Allergy & Anaphylaxis Network, which states
Spelt is an ancient wheat that has recently been marketed as safe for wheat-allergic individuals. This claim is untrue, however. Wheat-allergic patients can react as readily to spelt as they do to common wheat.
Food & Wine isn't alone in making such serious mistakes when covering McKenna and her Babycakes bakery, which has marketed spelt cupcakes as being free of wheat. Earlier this year, New York wrote that a Babycakes cupcake was free of wheat even though spelt was among its ingredients. More recently, Manhattan User's Guide described Babycakes as a "gluten-free bakery" despite its use of spelt.

These days, the BabyCakes website includes this disclaimer:
BabyCakes menu is ever expanding to create safe options for all. Although we try, we are unable to accommodate every allergy. Ultimately, it is the consumer’s responsibility to check all ingredients to ensure safe indulgence. Although Agave Nectar is known to be a healthful sugar-free alternative for those with diabetes, not all diabetics are the same and should check with their doctor to make sure Agave Nectar suits their diet.
Silver lining time: At least the other two McKenna recipes in Food & Wine--for Brownie Bites and Cinnamon Banana Bread--are okay for people on medical gluten-free diets.

Friday, September 08, 2006

MORE CUTE COOKING!

I just couldn't keep myself away from Cooking Cute.

Here's Beary good friends.

Here's Blog Day bento.

And, for old time's sake, here's the Totoro!

Previous coverage here

Friday, September 01, 2006

TESTING FOR CELIAC DISEASE

There is a well-established test protocol for celiac disease: A physician takes a set of blood tests during a period when the patient has not been on a gluten-free diet; then, depending on the results of the test, a physician might proceed with an upper endoscopy, long known as the gold standard for a celiac diagnosis.

The reason the blood tests must be taken when the patient has not been on a gluten-free diet is that the tests measure the patient's reaction (or lack of reaction) to gluten in the diet. (The longer a patient has been gluten-free, the less chance there is of measuring anything and getting useful results.)

Some physicians might want to take only one or two blood tests, but the Celiac Disease Center at Columbia University recommends the following set to maximize the chance of getting accurate results:
Anti-gliadin antibodies (AGA) both IgA and IgG
Anti-endomysial antibodies (EMA) - IgA
Anti-tissue transglutaminase antibodies (tTG) - IgA
Total IgA level
When it comes to the biopsy, care must be taken to ensure that at least 4 to 6 biopsy pieces be taken, that the orientation of the biopsies be done properly, and that, in the words of the Celiac Disease Center at Columbia University, "If the biopsy interpretation does not match either the clinical impression or serologic results the biopsy should be re-interpreted by a pathologist expert in the interpretation of gastrointestinal pathology." In other words, if the results of the testing seem to be inconclusive, an expert pathologist should review them.

Genetic tests are not a substitute for the above diagnostic process. At present, genetic tests can, at best, determine whether a patient is extremely unlikely to have celiac disease. They will not tell whether a patient has it.

In fact, no other diagnostic tests have yet been proven to be equal or superior to the blood test/biopsy protocol. One might, for instance, find references on the Internet to a stool test offered by Enterolab, but as of the time of this writing this test has neither been accepted by the medical community nor independently shown to be more reliable than the aforementioned protocol.

As recently as last June, Dr. Alessio Fasano of the University of Maryland Center for Celiac Research had the following exchange in the Clan Thompson Celiac Newsletter (Issue #83/June 21, 2006):
Dear Doctor, I was recently diagnosed with gluten sensitivity through a stool test. Simple, non-invasive, and cheap! While it doesn't tell me if I have intestinal damage, I really don't care because the treatment will be the same, regardless. I have reversed my bone density loss with a (nearly) gluten free diet, have no digestive complaints, and feel great. Why are stool tests for antibodies not used more frequently since they are so darn cheap? Is the mainstream medical establishment opposed to their use for some reason? Thanks, Jenny

Hi Jenny: The only reason why the stool tests are not as diffuse as the classic blood test is that they are not validated and, therefore, they are not recognized by the official organs that govern the laboratories [sic] activities. I am pretty sure that if other labs and other scientists will validate the stool test, it will be likely that this test will be used more wisely. Unfortunately, after many years, nobody has been able to reproduce the validity of this test. Sincerely, Alessio Fasano, M.D.
And just yesterday, Andrea Levario of the American Celiac Disease Alliance shared the following on the international celiac disease mailing list:
The tests being conducted at Enterolab are not "definitive" for celiac disease. In reviewing information on the Enterolab website, it states they are testing for "gluten sensitivity" and not celiac disease.

There are well accepted criteria for the detection and diagnosis of celiac disease. The tests used to fulfill these criteria have been subjected to scientific scrutiny and validation. To our knowledge tests of antibodies in stool or saliva have not been validated as a robust test for the diagnosis of celiac disease. Many insurance companies base their decision to cover the costs of testing on the scientific evidence that supports the testing of that individual (indication) and the actual test used (validation).

Our organization relies on the expertise of its physician members, as well as the recommendations of the:
- American College of Gastroenterology;

- North American Society for Pediatric Gastroenterology,

- Hepatology and Nutrition (NASPGHAN);

- NIH Consensus Panel on Celiac Disease; and

- Childrens Digestive Health and Nutrition Foundation
for the most current scientifically proven information on the diagnosis of celiac disease.
Alternate testing methods are being explored, but at present the diagnosis of celiac disease is best done by well-informed medical professionals using the blood test/biopsy protocol.